Cohort Study of Risk Reducing Salpingectomy
RRS
1 other identifier
interventional
18
1 country
1
Brief Summary
Women undergoing surgical sterilization will be interested in risk reducing salpingectomy, and surgeons performing the procedure will be able to successfully complete the salpingectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 13, 2014
CompletedFirst Posted
Study publicly available on registry
June 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedApril 25, 2017
April 1, 2017
1.2 years
June 13, 2014
April 21, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Percent of women accepting RRS
Determination of patient demand/interest in pursuing RRS for sterilization during 12-month study period
12 months
Secondary Outcomes (1)
Percent of women with successful RRS completion
12 months
Study Arms (2)
Salpingectomy
EXPERIMENTALParticipants will be offered a risk-reducing salpingectomy, and if they choose this options the surgeon will proceed with a salpingectomy.
Traditional sterilization
ACTIVE COMPARATORParticipants will be offered a risk-reducing salpingectomy, and those that choose a traditional sterilization will be in this treatment arm.
Interventions
Eligibility Criteria
You may qualify if:
- Women \> 35 years requesting sterilization as interval procedure OR at time of cesarean delivery
- At least one living child
- English or Spanish speaking
- Sterilization planned as interval (laparoscopic) procedure via Family Planning Clinic services or at time of delivery
- Delivery by cesarean section (planned or following labor)
You may not qualify if:
- Age \< 30
- Medical complications that increase risk for surgical bleeding (e.g. Idiopathic thrombocytopenic purpura (ITP); von Willebrand disease (vWD); need for prophylactic or therapeutic anticoagulation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Carolina, Chapel Hilllead
- Medtronic - MITGcollaborator
Study Sites (1)
University of North Carolina Hosptials
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew L Zerden, MD, MPH
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2014
First Posted
June 17, 2014
Study Start
June 1, 2014
Primary Completion
August 1, 2015
Study Completion
September 1, 2015
Last Updated
April 25, 2017
Record last verified: 2017-04